Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 283 entries
Sorted by: Best Match Show Resources per page
The ERA trial: findings and implications for the future.

Climacteric : the journal of the International Menopause Society

Nair GV, Herrington DM.
PMID: 11910581
Climacteric. 2000 Dec;3(4):227-32. doi: 10.1080/13697130008500132.

No abstract available.

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study.


Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M.
PMID: 12821545
Circulation. 2003 Jul 15;108(2):166-70. doi: 10.1161/01.CIR.0000079160.07364.6A. Epub 2003 Jun 23.

BACKGROUND: Increased carotid artery intima-media thickness (IMT) and elevated C-reactive protein (CRP) are both associated with the occurrence of stroke. We investigated whether elevated CRP is a risk factor for ischemic stroke independent of carotid IMT and studied the...

Determination of femoral artery endothelial function by phase contrast magnetic resonance imaging.

The American journal of cardiology

Alexander MR, Kitzman DW, Khaliq S, Darty SN, Hamilton CA, Herrington DM, Link KM, Hundley WG.
PMID: 11704017
Am J Cardiol. 2001 Nov 01;88(9):1070-4. doi: 10.1016/s0002-9149(01)01998-1.

No abstract available.

The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?.

Drugs & aging

Wells G, Herrington DM.
PMID: 10641952
Drugs Aging. 1999 Dec;15(6):419-22. doi: 10.2165/00002512-199915060-00001.

The Heart and Estrogen/Progestin Replacement Study (HERS) was the first randomised, double-blind, placebo-controlled study to evaluate the outcome of hormone replacement therapy (HRT) on subsequent cardiac events in postmenopausal women with established coronary heart disease (CHD). Of the 2763...

Dehydroepiandrosterone and cardiac allograft vasculopathy.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Herrington DM, Nanjee N, Achuff SC, Cameron DE, Dobbs B, Baughman KL.
PMID: 8820087
J Heart Lung Transplant. 1996 Jan;15(1):88-93.

BACKGROUND: Tissue culture, animal model, and epidemiologic studies suggest that dehydroepiandrosterone may inhibit atherosclerosis through its potent antiproliferative effects. Because cardiac allograft vasculopathy is predominantly a proliferative abnormality of intimal and medial smooth muscle cells, plasma levels of dehydroepiandrosterone...

Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging.


Hundley WG, Hamilton CA, Clarke GD, Hillis LD, Herrington DM, Lange RA, Applegate RJ, Thomas MS, Payne J, Link KM, Peshock RM.
PMID: 10385498
Circulation. 1999 Jun 29;99(25):3248-54. doi: 10.1161/01.cir.99.25.3248.

BACKGROUND: Coronary artery bypass grafting improves survival in patients with >70% luminal diameter narrowing of the 3 major epicardial coronary arteries, particularly if there is involvement of the proximal portion of the left anterior descending (LAD) coronary artery. Measurement...

Cardiovascular trials of estrogen replacement therapy.

Annals of the New York Academy of Sciences

Herrington DM, Klein KP.
PMID: 11795347
Ann N Y Acad Sci. 2001 Dec;949:153-62. doi: 10.1111/j.1749-6632.2001.tb04014.x.

An impressive body of evidence has suggested that estrogen therapy should be helpful to slow the pathogenesis or progression of atherosclerosis. Estrogen's favorable effects on lipids and endothelial function, coupled with extensive observational epidemiology and data from animal models...

Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function.

Women's health issues : official publication of the Jacobs Institute of Women's Health

Herrington DM, Klein KP.
PMID: 11275512
Womens Health Issues. 2001 Mar-Apr;11(2):95-102. doi: 10.1016/s1049-3867(01)00075-5.

No abstract available.

beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.

American journal of hypertension

Hindorff LA, Heckbert SR, Psaty BM, Lumley T, Siscovick DS, Herrington DM, Edwards KL, Tracy RP.
PMID: 15797659
Am J Hypertens. 2005 Mar;18(3):392-7. doi: 10.1016/j.amjhyper.2004.10.014.

BACKGROUND: Common Arg16Gly and Gln27Glu polymorphisms of the beta(2)-adrenergic receptor (beta(2)AR) have been associated with hypertension and coronary disease. This analysis of older adults in the Cardiovascular Health Study examined whether these polymorphisms were associated with blood pressure (BP),...

Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort.

American heart journal

Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Herrington DM.
PMID: 16923436
Am Heart J. 2006 Sep;152(3):593-8. doi: 10.1016/j.ahj.2006.02.015.

BACKGROUND: American Heart Association/Centers for Disease Control and Prevention guidelines support the measurement of C-reactive protein (CRP) to further risk stratify individuals at intermediate risk (10%-20% 10-year risk) for heart disease. Determining gender-specific differences in CRP may alter how...

The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM.
PMID: 15211434
Am J Kidney Dis. 2004 Jul;44(1):25-34. doi: 10.1053/j.ajkd.2004.03.022.

BACKGROUND: Microalbuminuria is a risk factor for coronary heart disease (CHD). It occurs most commonly in the settings of diabetes and hypertension. The mechanisms by which it increases CHD risk are uncertain.METHODS: We examined the cross-sectional association of microalbuminuria...

Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

American heart journal

Lakoski SG, Brosnihan B, Herrington DM.
PMID: 16290959
Am Heart J. 2005 Nov;150(5):907-11. doi: 10.1016/j.ahj.2004.11.025.

OBJECTIVE: To compare the effects of estrogen and estrogen plus progestin on levels of C-reactive protein (CRP) and interleukin-6 (IL-6), and to examine the relationship between these changes and progression of angiographically defined coronary disease.METHODS: Baseline and follow-up (year...

Showing 1 to 12 of 283 entries